Coppell Advisory Solutions’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37
| Closed | -$2.46K | – | 1407 |
|
|
2024
Q4 | $2.46K | Hold |
37
| – | – | ﹤0.01% | 1501 |
|
|
2024
Q3 | $2.58K | Buy |
+37
| New | +$2.58K | ﹤0.01% | 1395 |
|
|
2023
Q4 | $805 | Hold |
13
| – | – | ﹤0.01% | 1452 |
|
|
2023
Q3 | $825 | Hold |
13
| – | – | ﹤0.01% | 954 |
|
|
2023
Q2 | $783 | Buy |
+13
| New | +$783 | ﹤0.01% | 1179 |
|
|
2023
Q1 | – | Sell |
-13
| Closed | -$825 | – | 801 |
|
|
2022
Q4 | $825 | Buy |
+13
| New | +$825 | ﹤0.01% | 955 |
|